Hepatitis B and C are viral infections that primarily affect the liver, leading to inflammation and, in severe cases, liver damage or failure. Both viruses are part of the hepatitis family but differ significantly in their transmission, symptoms, and long-term health effects. Hepatitis B (HBV) is a DNA virus, while hepatitis C (HCV) is an RNA virus. Understanding these differences is crucial for prevention and treatment.

Transmission methods for hepatitis B include exposure to infectious body fluids, such as blood, semen, or vaginal secretions. Common ways the virus spreads are through unprotected sexual contact, sharing needles among drug users, and from mother to child during childbirth. It is also important to note that hepatitis B can survive outside the body for at least seven days, making it possible to contract HBV from contact with contaminated surfaces.

Hepatitis C, on the other hand, is primarily spread through direct blood-to-blood contact. This can occur through sharing needles or other equipment used to inject drugs. While sexual transmission of HCV is less common than with HBV, it can still occur, particularly among individuals with multiple sexual partners or those who engage in high-risk sexual behavior. Unlike hepatitis B, hepatitis C does not have a vaccine, emphasizing the importance of preventive measures.

Preventive actions are essential to reduce the risk of both hepatitis B and C. Vaccination is available for hepatitis B, making it crucial for at-risk populations to receive it. Additionally, practicing safer sex, avoiding sharing needles or personal items like razors, and ensuring proper sterilization of medical instruments can help prevent the spread of both viruses. Regular testing is also advised for individuals who may be at risk, along with open conversations about sexual health and consent.